Lilly Trade Secrets Theft Case In China Puts Spotlight On Prevalent Problem
This article was originally published in The Pink Sheet Daily
Two former Lilly biologists are indicted in the U.S. for passing early research in cancer, diabetes and metabolic disorders to Hengrui, a Chinese competitor. While few such cases become public, it is a constant worry for industry.
You may also be interested in...
Pfizer says its former global marketing director emailed and copied hundreds of documents on product launch plans and steps to obtain government approvals before leaving the company in January.
Pink Sheet reporter and editors examine the struggle over the FDA’s reputation, whether a coronavirus vaccine could be made available without sponsor cooperation, and the late Supreme Court Justice Ruth Bader Ginsburg’s legacy for pharma.
Governor Cuomo will establish two panels, one examining safety and efficacy and another considering distribution and pricing, to advise the state on how to approach use of coronavirus vaccines once one is approved.